Everolimus Safety Profile in Liver Transplant Recipients With 3-Year Exposure in the H2304 Core and Extension Study.

被引：0
|
作者：
Saliba, F. [1 ]
Rogiers, X. [1 ]
Chapman, W. [1 ]
Caicedo, L. [1 ]
Alsina, A. [1 ]
Teperman, L. [1 ]
Junge, G. [1 ]
Rauer, B. [1 ]
Dong, G. [1 ]
De Simone, P. [1 ]
机构：
[1] H2304E1 Study Grp, Villejuif, France
来源：
LIVER TRANSPLANTATION | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-310
引用
收藏
页码：S247 / S248
页数：2
相关论文
共 50 条
  • [21] Effect of Donor-Recipient Gender Mismatch in Liver Transplant Recipients: A Post-Hoc Analysis of the H2304 Study
    Fischer, L.
    de Simone, P.
    Dong, G.
    Lopez, P.
    Bernhardt, P.
    Saliba, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 753 - 753
  • [22] Evolution of Renal Function with Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Foltys, D.
    Koneru, B.
    Wang, Y.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 238 - 238
  • [23] Impact of Everolimus-Based Immunosuppression on Efficacy, Safety and Progression of Fibrosis in Hepatitis C Virus Positive De Novo Liver Transplant Recipients: 12 Months Results from H2304 Study
    Beckebaum, S.
    Chavin, K. D.
    Teperman, L.
    Wiederkehr, J.
    Trunecka, P.
    Dong, G.
    Junge, G.
    Lopez, P.
    Duvoux, C.
    TRANSPLANTATION, 2012, 94 (10) : 8 - 8
  • [24] POST-LIVER TRANSPLANTATION HEPATOCELLULAR CARCINOMA RECURRENCE WITH EVEROLIMUS TREATMENT: RESULTS FROM THE H2304 STUDY
    Fischer, L.
    Saliba, F.
    De Simone, P.
    Dong, G.
    Speziale, A.
    Lopez, P.
    Junge, G.
    Fung, J.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 88 - 89
  • [25] Renal Function and HCC Recurrence As Well As Safety of Everolimus with Reduced Tacrolimus Versus Standard Tacrolimus in Deceased and Living Donor Liver Transplant Recipients: Pooled Analysis of H2304 and H2307 Studies
    Lee, Sung Gyu
    Jeng, Long Bin
    Saliba, Faouzi
    Soin, Arvinder Singh
    Lee, Wei-Chen
    De Simone, Paolo
    Nevens, Frederik
    Suh, Kyung-Suk
    Fischer, Lutz
    Joo, DongJin
    Fung, John J.
    Joh, Jae-Won
    Kaido, Toshimi
    Grant, David R.
    Meier, Matthias
    Barbara, Rauer
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary A.
    HEPATOLOGY, 2018, 68 : 6A - 6A
  • [26] Impact of Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus on the Evolution of Renal Function in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study
    Metselaar, H. J.
    Saliba, F.
    Schemmer, P.
    Foltys, D.
    Fabregat, J.
    Ericzon, B. -G.
    Dong, G.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    TRANSPLANTATION, 2012, 94 (10) : 44 - 44
  • [27] Everolimus With Reduced Exposure to a Calcineurin Inhibitor in Pediatric Liver Transplant Recipients: Baseline Data From the H2305 Study.
    Ganschow, R.
    Fischer, L.
    Ericzon, B.
    Dhawan, A.
    D'Alessandro, A.
    Goss, J.
    Sips, C.
    Balfour, A.
    Junge, G.
    TRANSPLANTATION, 2014, 98 : 719 - 719
  • [28] Everolimus With Reduced Exposure to a Calcineurin Inhibitor in Pediatric Liver Transplant Recipients: Baseline Data From the H2305 Study.
    Ganschow, R.
    Fischer, L.
    Ericzon, B.
    Dhawan, A.
    D'Alessandro, A.
    Goss, J.
    Sips, C.
    Balfour, A.
    Junge, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 719 - 719
  • [29] EVEROLIMUS WITH REDUCED TACROLIMUS PROVIDES IMPROVED RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS: A MELD SCORE SUBGROUP ANALYSES FROM THE RANDOMISED-CONTROLLED H2304 STUDY AT MONTH 12 AND 24
    Saliba, Faouzi
    Fischer, Lutz
    De Simone, Paolo
    Dong, Gaohong
    Escrig, Cesar
    Lopez, Patricia
    TRANSPLANT INTERNATIONAL, 2015, 28 : 199 - 200
  • [30] Long-term clinical outcomes evaluation of everolimus in liver transplant patients with autoimmune liver diseases: Pooled analysis from the H2304 and PROTECT trials
    Fung, John
    Charlton, Michael
    Saliba, Faouzi
    Schlitt, Hans J.
    Mccague, Kevin
    Junge, Guido
    Lopez, Patricia M.
    Patel, Dharmesh
    Sterneck, Martina R.
    HEPATOLOGY, 2017, 66 : 899A - 899A
12345